NO306395B1 - Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav - Google Patents

Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav

Info

Publication number
NO306395B1
NO306395B1 NO951532A NO951532A NO306395B1 NO 306395 B1 NO306395 B1 NO 306395B1 NO 951532 A NO951532 A NO 951532A NO 951532 A NO951532 A NO 951532A NO 306395 B1 NO306395 B1 NO 306395B1
Authority
NO
Norway
Prior art keywords
preparation
processes
compound
pct
well
Prior art date
Application number
NO951532A
Other languages
English (en)
Norwegian (no)
Other versions
NO951532L (no
NO951532D0 (no
Inventor
Wolfgang Herrmann
Armin Knapp
Hans Klausmann
Joachim Witzke
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of NO951532L publication Critical patent/NO951532L/no
Publication of NO951532D0 publication Critical patent/NO951532D0/no
Publication of NO306395B1 publication Critical patent/NO306395B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO951532A 1992-10-26 1995-04-21 Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav NO306395B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4236074 1992-10-26
PCT/EP1993/002954 WO1994010129A1 (de) 1992-10-26 1993-10-25 Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen

Publications (3)

Publication Number Publication Date
NO951532L NO951532L (no) 1995-04-21
NO951532D0 NO951532D0 (no) 1995-04-21
NO306395B1 true NO306395B1 (no) 1999-11-01

Family

ID=6471354

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951532A NO306395B1 (no) 1992-10-26 1995-04-21 Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav

Country Status (24)

Country Link
US (1) US5693669A (fi)
EP (1) EP0665830B1 (fi)
JP (1) JP3266261B2 (fi)
KR (1) KR100310041B1 (fi)
AT (1) ATE150004T1 (fi)
AU (1) AU683229B2 (fi)
BG (1) BG61944B1 (fi)
CA (1) CA2147759C (fi)
CZ (1) CZ285637B6 (fi)
DE (1) DE59305805D1 (fi)
DK (1) DK0665830T3 (fi)
ES (1) ES2098792T3 (fi)
FI (1) FI113642B (fi)
GR (1) GR3023186T3 (fi)
HU (1) HU219344B (fi)
MX (1) MX9306607A (fi)
NO (1) NO306395B1 (fi)
NZ (1) NZ257338A (fi)
PL (2) PL174197B1 (fi)
RO (1) RO112851B1 (fi)
RU (1) RU2123998C1 (fi)
SK (1) SK281041B6 (fi)
UA (1) UA42704C2 (fi)
WO (1) WO1994010129A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE210983T1 (de) * 1997-11-03 2002-01-15 Stada Arzneimittel Ag Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
ATE242760T1 (de) * 1998-04-28 2003-06-15 Russinsky Ltd Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
ATE261302T1 (de) * 1998-05-28 2004-03-15 Krewel Meuselbach Gmbh Retardiertes schmerzmittel enthaltend tilidin
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
DE19915602A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE29908435U1 (de) * 1999-05-11 1999-08-05 Krewel Meuselbach GmbH, 53783 Eitorf Dosiervorrichtung
DE50303646D1 (de) * 2002-06-28 2006-07-20 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung enthaltend Tilidinhydrochlorid
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
EP2168945A1 (en) 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1793571B1 (de) * 1965-11-19 1971-12-30 Goedecke Ag 3t-Dimethylamino-4-phenyl-4t-carbaethoxy-delta?-cyclohexen und dessen Hydrochlorid
FR5978M (fi) * 1965-11-19 1968-04-22
US4933438A (en) * 1984-02-29 1990-06-12 University Of Florida Brain-specific analogues of centrally acting amines
US4800083A (en) * 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level

Also Published As

Publication number Publication date
FI951961A0 (fi) 1995-04-25
DE59305805D1 (de) 1997-04-17
KR100310041B1 (ko) 2002-04-24
AU683229B2 (en) 1997-11-06
JP3266261B2 (ja) 2002-03-18
JPH08502505A (ja) 1996-03-19
UA42704C2 (uk) 2001-11-15
MX9306607A (es) 1994-04-29
SK52895A3 (en) 1995-12-06
SK281041B6 (sk) 2000-11-07
NO951532L (no) 1995-04-21
ATE150004T1 (de) 1997-03-15
CZ285637B6 (cs) 1999-10-13
EP0665830B1 (de) 1997-03-12
CA2147759C (en) 2004-08-10
FI113642B (fi) 2004-05-31
NZ257338A (en) 1996-03-26
BG99565A (bg) 1996-01-31
HU9501170D0 (en) 1995-06-28
HU219344B (en) 2001-03-28
PL308358A1 (en) 1995-07-24
US5693669A (en) 1997-12-02
RO112851B1 (ro) 1998-01-30
RU95113437A (ru) 1997-02-20
NO951532D0 (no) 1995-04-21
RU2123998C1 (ru) 1998-12-27
PL174739B1 (pl) 1998-09-30
FI951961A (fi) 1995-04-25
BG61944B1 (bg) 1998-10-30
DK0665830T3 (da) 1997-09-01
WO1994010129A1 (de) 1994-05-11
HUT73787A (en) 1996-09-30
EP0665830A1 (de) 1995-08-09
ES2098792T3 (es) 1997-05-01
GR3023186T3 (en) 1997-07-30
CZ105295A3 (en) 1995-10-18
AU5370894A (en) 1994-05-24
KR950703518A (ko) 1995-09-20
PL174197B1 (pl) 1998-06-30
CA2147759A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
NO302570B1 (no) Substituerte pipekolinsyrederivater som HIV-protease-inhibitorer, farmasöytiske blandinger inneholdende dem og anvendelser av derivatene
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
BG104727A (en) Pharmaceutical composition of topiramate
IL109448A0 (en) Risperidone pamoate, its preparation and pharmaceutical compositions containing it
HUP0002296A2 (hu) Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
HUP0000838A2 (hu) Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények
HUP0104495A2 (hu) N-szubsztituált 2-ciano-pirrolidinek és ezeket tartalmazó gyógyászati készítmények
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
NO306395B1 (no) Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
EP0695184A4 (en) HIV PROTEASE INHIBITORS
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
HUP9904638A2 (hu) Szubsztituált benzopiránszármazékok alkalmazása gyógyszerkészítmények előállítására
GEP20043377B (en) Pharmaceutical Complex

Legal Events

Date Code Title Description
MK1K Patent expired